No therapeutic indication in the current trial with healthy volunteers. The intended indication is for intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson’s disease (PD) treated with a levodopa/dopa-decarboxylase inhibitor.

• A Pilot Open-label, Randomized, Crossover, Comparative Bioavailability Study of Levodopa Administered via Levodopa Cyclops™ (test product) R … Ended
  2023-504687-42-00 3 2023-09-19

Showing 1–1 of 1 trials